Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells.

Gargaro M, Vacca C, Massari S, Scalisi G, Manni G, Mondanelli G, Mazza EMC, Bicciato S, Pallotta MT, Orabona C, Belladonna ML, Volpi C, Bianchi R, Matino D, Iacono A, Panfili E, Proietti E, Iamandii IM, Cecchetti V, Puccetti P, Tabarrini O, Fallarino F, Grohmann U.

Front Immunol. 2019 Aug 20;10:1973. doi: 10.3389/fimmu.2019.01973. eCollection 2019.

2.

Exposure to moderate air pollution and associations with lung function at school-age: A birth cohort study.

Usemann J, Decrue F, Korten I, Proietti E, Gorlanova O, Vienneau D, Fuchs O, Latzin P, Röösli M, Frey U; BILD study group.

Environ Int. 2019 May;126:682-689. doi: 10.1016/j.envint.2018.12.019. Epub 2019 Mar 11.

3.

Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study.

Lonardi S, Nasti G, Fagnani D, Gemma D, Ciuffreda L, Granetto C, Lucchesi S, Ballestrero A, Biglietto M, Proserpio I, Bergamo F, Proietti E, Tonini G.

Tumori. 2019 Jun;105(3):243-252. doi: 10.1177/0300891619834126. Epub 2019 Mar 11.

PMID:
30857495
4.

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients.

Palermo B, Franzese O, Donna CD, Panetta M, Quintarelli C, Sperduti I, Gualtieri N, Foddai ML, Proietti E, Ferraresi V, Ciliberto G, Nisticò P.

Oncoimmunology. 2018 Sep 11;7(12):e1465163. doi: 10.1080/2162402X.2018.1465163. eCollection 2018.

5.

Variability of Tidal Breathing Parameters in Preterm Infants and Associations with Respiratory Morbidity during Infancy: A Cohort Study.

Usemann J, Suter A, Zannin E, Proietti E, Fouzas S, Schulzke S, Latzin P, Frey U; BILD study group.

J Pediatr. 2019 Feb;205:61-69.e1. doi: 10.1016/j.jpeds.2018.10.002. Epub 2018 Nov 8.

PMID:
30416016
6.

Paper-Based Strips for the Electrochemical Detection of Single and Double Stranded DNA.

Cinti S, Proietti E, Casotto F, Moscone D, Arduini F.

Anal Chem. 2018 Nov 20;90(22):13680-13686. doi: 10.1021/acs.analchem.8b04052. Epub 2018 Oct 30.

PMID:
30338973
7.

Response of cord blood cells to environmental, hereditary and perinatal factors: A prospective birth cohort study.

Lurà MP, Gorlanova O, Müller L, Proietti E, Vienneau D, Reppucci D, Pavlovic R, Dahinden C, Röösli M, Latzin P, Frey U.

PLoS One. 2018 Jul 6;13(7):e0200236. doi: 10.1371/journal.pone.0200236. eCollection 2018.

8.

Glucocorticoid metabolites in newborns: A marker for traffic noise related stress?

Cantuaria ML, Usemann J, Proietti E, Blanes-Vidal V, Dick B, Flück CE, Rüedi S, Héritier H, Wunderli JM, Latzin P, Frey U, Röösli M, Vienneau D; BILD study group.

Environ Int. 2018 Aug;117:319-326. doi: 10.1016/j.envint.2018.05.002. Epub 2018 May 17.

PMID:
29778832
9.

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.

Castiello L, Sestili P, Schiavoni G, Dattilo R, Monque DM, Ciaffoni F, Iezzi M, Lamolinara A, Sistigu A, Moschella F, Pacca AM, Macchia D, Ferrantini M, Zeuner A, Biffoni M, Proietti E, Belardelli F, Aricò E.

Cancer Immunol Res. 2018 Jun;6(6):658-670. doi: 10.1158/2326-6066.CIR-17-0675. Epub 2018 Apr 5.

10.

Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.

Anticoli S, Aricò E, Arenaccio C, Manfredi F, Chiozzini C, Olivetta E, Ferrantelli F, Lattanzi L, D'Urso MT, Proietti E, Federico M.

J Mol Med (Berl). 2018 Feb;96(2):211-221. doi: 10.1007/s00109-017-1617-2. Epub 2017 Dec 27.

PMID:
29282521
11.

Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide.

Buccione C, Fragale A, Polverino F, Ziccheddu G, Aricò E, Belardelli F, Proietti E, Battistini A, Moschella F.

Int J Cancer. 2018 Mar 1;142(5):976-987. doi: 10.1002/ijc.31083. Epub 2017 Oct 16.

12.

The added value of type I interferons to cytotoxic treatments of cancer.

Bracci L, Sistigu A, Proietti E, Moschella F.

Cytokine Growth Factor Rev. 2017 Aug;36:89-97. doi: 10.1016/j.cytogfr.2017.06.008. Epub 2017 Jun 19. Review.

PMID:
28693974
13.

Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).

Russo V, Amadori A, Bregni M, Calabrò L, Colombo MP, Di Nicola M, Ferrucci PF, Proietti E, Maio M, Bellone M.

Cytokine Growth Factor Rev. 2017 Aug;36:1-3. doi: 10.1016/j.cytogfr.2017.06.004. Epub 2017 Jun 16.

PMID:
28634022
14.

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis.

Aricò E, Sestili P, Carpinelli G, Canese R, Cecchetti S, Schiavoni G, D'Urso MT, Belardelli F, Proietti E.

Oncotarget. 2016 Sep 13;7(37):59754-59765. doi: 10.18632/oncotarget.10880.

15.

A broadband toolbox for scanning microwave microscopy transmission measurements.

Lucibello A, Sardi GM, Capoccia G, Proietti E, Marcelli R, Kasper M, Gramse G, Kienberger F.

Rev Sci Instrum. 2016 May;87(5):053701. doi: 10.1063/1.4948291.

PMID:
27250429
16.

Air pollution modelling for birth cohorts: a time-space regression model.

Proietti E, Delgado-Eckert E, Vienneau D, Stern G, Tsai MY, Latzin P, Frey U, Röösli M.

Environ Health. 2016 May 25;15(1):61. doi: 10.1186/s12940-016-0145-9.

17.

Effects of Breastfeeding on Respiratory Symptoms in Infancy.

Gorlanova O, Thalmann S, Proietti E, Stern G, Latzin P, Kühni C, Röösli M, Frey U.

J Pediatr. 2016 Jul;174:111-117.e5. doi: 10.1016/j.jpeds.2016.03.041. Epub 2016 Apr 7.

PMID:
27063808
18.

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.

Brandes AA, Finocchiaro G, Zagonel V, Reni M, Caserta C, Fabi A, Clavarezza M, Maiello E, Eoli M, Lombardi G, Monteforte M, Proietti E, Agati R, Eusebi V, Franceschi E.

Neuro Oncol. 2016 Sep;18(9):1304-12. doi: 10.1093/neuonc/now035. Epub 2016 Mar 6.

19.

Sigh-induced changes of breathing pattern in preterm infants.

Jost K, Latzin P, Fouzas S, Proietti E, Delgado-Eckert EW, Frey U, Schulzke SM.

Physiol Rep. 2015 Nov;3(11). pii: e12613. doi: 10.14814/phy2.12613.

20.

Development of Late-Onset Preeclampsia in Association with Road Densities as a Proxy for Traffic-Related Air Pollution.

Wu M, Ries JJ, Proietti E, Vogt D, Hahn S, Hoesli I.

Fetal Diagn Ther. 2016;39(1):21-7. doi: 10.1159/000381802. Epub 2015 Jun 17.

21.

Consensus guidelines for the detection of immunogenic cell death.

Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, Cirone M, Colombo MI, Cremer I, Demaria S, Dini L, Eliopoulos AG, Faggioni A, Formenti SC, Fučíková J, Gabriele L, Gaipl US, Galon J, Garg A, Ghiringhelli F, Giese NA, Guo ZS, Hemminki A, Herrmann M, Hodge JW, Holdenrieder S, Honeychurch J, Hu HM, Huang X, Illidge TM, Kono K, Korbelik M, Krysko DV, Loi S, Lowenstein PR, Lugli E, Ma Y, Madeo F, Manfredi AA, Martins I, Mavilio D, Menger L, Merendino N, Michaud M, Mignot G, Mossman KL, Multhoff G, Oehler R, Palombo F, Panaretakis T, Pol J, Proietti E, Ricci JE, Riganti C, Rovere-Querini P, Rubartelli A, Sistigu A, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Sukkurwala AQ, Tartour E, Thorburn A, Thorne SH, Vandenabeele P, Velotti F, Workenhe ST, Yang H, Zong WX, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Dec 13;3(9):e955691. eCollection 2014 Oct. Review.

22.

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.

Rozera C, Cappellini GA, D'Agostino G, Santodonato L, Castiello L, Urbani F, Macchia I, Aricò E, Casorelli I, Sestili P, Montefiore E, Monque D, Carlei D, Napolitano M, Rizza P, Moschella F, Buccione C, Belli R, Proietti E, Pavan A, Marchetti P, Belardelli F, Capone I.

J Transl Med. 2015 May 2;13:139. doi: 10.1186/s12967-015-0473-5.

23.

Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic use.

Antonelli G, Scagnolari C, Moschella F, Proietti E.

Cytokine Growth Factor Rev. 2015 Apr;26(2):121-31. doi: 10.1016/j.cytogfr.2014.12.006. Epub 2014 Dec 30. Review.

PMID:
25578520
24.

Lactate dehydrogenase concentration in nasal wash fluid indicates severity of rhinovirus-induced wheezy bronchitis in preschool children.

Cangiano G, Proietti E, Kronig MN, Kieninger E, Sadeghi CD, Gorgievski M, Barbani MT, Midulla F, Tapparel C, Kaiser L, Alves MP, Regamey N.

Pediatr Infect Dis J. 2014 Dec;33(12):1285-7. doi: 10.1097/INF.0000000000000420.

PMID:
25389710
25.

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, Fend L, Hannani D, Aymeric L, Ma Y, Niso-Santano M, Kepp O, Schultze JL, Tüting T, Belardelli F, Bracci L, La Sorsa V, Ziccheddu G, Sestili P, Urbani F, Delorenzi M, Lacroix-Triki M, Quidville V, Conforti R, Spano JP, Pusztai L, Poirier-Colame V, Delaloge S, Penault-Llorca F, Ladoire S, Arnould L, Cyrta J, Dessoliers MC, Eggermont A, Bianchi ME, Pittet M, Engblom C, Pfirschke C, Préville X, Uzè G, Schreiber RD, Chow MT, Smyth MJ, Proietti E, André F, Kroemer G, Zitvogel L.

Nat Med. 2014 Nov;20(11):1301-9. doi: 10.1038/nm.3708. Epub 2014 Oct 26.

PMID:
25344738
26.

Can infant lung function predict respiratory morbidity during the first year of life in preterm infants?

Proietti E, Riedel T, Fuchs O, Pramana I, Singer F, Schmidt A, Kuehni C, Latzin P, Frey U.

Eur Respir J. 2014 Jun;43(6):1642-51. doi: 10.1183/09031936.00149213. Epub 2014 Apr 2.

27.

Validation of multiple-breath washout equipment for infants and young children.

Schmidt A, Yammine S, Proietti E, Frey U, Latzin P, Riedel T, Singer F.

Pediatr Pulmonol. 2015 Jun;50(6):607-14. doi: 10.1002/ppul.23010. Epub 2014 Feb 25.

PMID:
24574166
28.

The Janus face of cyclophosphamide: A sterile inflammatory response that potentiates cancer immunotherapy.

Ziccheddu G, Proietti E, Moschella F.

Oncoimmunology. 2013 Sep 1;2(9):e25789. Epub 2013 Jul 29.

29.

Immune monitoring in cancer vaccine clinical trials: critical issues of functional flow cytometry-based assays.

Macchia I, Urbani F, Proietti E.

Biomed Res Int. 2013;2013:726239. doi: 10.1155/2013/726239. Epub 2013 Sep 30. Review.

30.

Volumetric capnography in infants with bronchopulmonary dysplasia.

Fouzas S, Häcki C, Latzin P, Proietti E, Schulzke S, Frey U, Delgado-Eckert E.

J Pediatr. 2014 Feb;164(2):283-8.e1-3. doi: 10.1016/j.jpeds.2013.09.034. Epub 2013 Oct 22.

PMID:
24161220
31.

Exploiting dendritic cells in the development of cancer vaccines.

Bracci L, Capone I, Moschella F, Proietti E, Belardelli F.

Expert Rev Vaccines. 2013 Oct;12(10):1195-210. doi: 10.1586/14760584.2013.836905. Epub 2013 Oct 4. Review.

PMID:
24090117
32.

Ventilatory response to nitrogen multiple-breath washout in infants.

Singer F, Yammine S, Schmidt A, Proietti E, Kieninger E, Barben J, Casaulta C, Regamey N, Gustafsson P, Frey U, Latzin P.

Pediatr Pulmonol. 2014 Apr;49(4):342-7. doi: 10.1002/ppul.22841. Epub 2013 Jul 12.

PMID:
23853006
33.

Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy.

Moschella F, Torelli GF, Valentini M, Urbani F, Buccione C, Petrucci MT, Natalino F, Belardelli F, Foà R, Proietti E.

Clin Cancer Res. 2013 Aug 1;19(15):4249-61. doi: 10.1158/1078-0432.CCR-12-3666. Epub 2013 Jun 12.

34.

A prospective study of the impact of air pollution on respiratory symptoms and infections in infants.

Stern G, Latzin P, Röösli M, Fuchs O, Proietti E, Kuehni C, Frey U.

Am J Respir Crit Care Med. 2013 Jun 15;187(12):1341-8. doi: 10.1164/rccm.201211-2008OC.

PMID:
23594341
35.

Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008.

Schlapbach LJ, Adams M, Proietti E, Aebischer M, Grunt S, Borradori-Tolsa C, Bickle-Graz M, Bucher HU, Latal B, Natalucci G; Swiss Neonatal Network & Follow-up Group.

BMC Pediatr. 2012 Dec 28;12:198. doi: 10.1186/1471-2431-12-198.

36.

Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting.

Singer F, Kieninger E, Abbas C, Yammine S, Fuchs O, Proietti E, Regamey N, Casaulta C, Frey U, Latzin P.

Pediatr Pulmonol. 2013 Aug;48(8):739-46. doi: 10.1002/ppul.22651. Epub 2012 Aug 8.

PMID:
22888105
37.

Air pollution during pregnancy and neonatal outcome: a review.

Proietti E, Röösli M, Frey U, Latzin P.

J Aerosol Med Pulm Drug Deliv. 2013 Feb;26(1):9-23. doi: 10.1089/jamp.2011.0932. Epub 2012 Aug 2. Review.

PMID:
22856675
39.

Comparison of online single-breath vs. online multiple-breath exhaled nitric oxide in school-age children.

Fuchs O, Latzin P, Singer F, Petrus N, Proietti E, Kieninger E, Casaulta C, Frey U.

Pediatr Res. 2012 May;71(5):605-11. doi: 10.1038/pr.2012.13. Epub 2012 Feb 9.

PMID:
22322384
40.

Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

Proietti E, Moschella F, Capone I, Belardelli F.

Mol Oncol. 2012 Feb;6(1):1-14. doi: 10.1016/j.molonc.2011.11.005. Epub 2011 Dec 3. Review.

41.

Defining the critical hurdles in cancer immunotherapy.

Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Håkansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilholtz U, Khleif SN, Kiessling R, Kotlan B, Kroemer G, Lapointe R, Levitsky HI, Lotze MT, Maccalli C, Maio M, Marschner JP, Mastrangelo MJ, Masucci G, Melero I, Melief C, Murphy WJ, Nelson B, Nicolini A, Nishimura MI, Odunsi K, Ohashi PS, O'Donnell-Tormey J, Old LJ, Ottensmeier C, Papamichail M, Parmiani G, Pawelec G, Proietti E, Qin S, Rees R, Ribas A, Ridolfi R, Ritter G, Rivoltini L, Romero PJ, Salem ML, Scheper RJ, Seliger B, Sharma P, Shiku H, Singh-Jasuja H, Song W, Straten PT, Tahara H, Tian Z, van Der Burg SH, von Hoegen P, Wang E, Welters MJ, Winter H, Withington T, Wolchok JD, Xiao W, Zitvogel L, Zwierzina H, Marincola FM, Gajewski TF, Wigginton JM, Disis ML.

J Transl Med. 2011 Dec 14;9:214. doi: 10.1186/1479-5876-9-214.

42.

Unveiling N-protonation and anion-binding effects on Fe/N/C-catalysts for O2 reduction in PEM fuel cells.

Herranz J, Jaouen F, Lefèvre M, Kramm UI, Proietti E, Dodelet JP, Bogdanoff P, Fiechter S, Abs-Wurmbach I, Bertrand P, Arruda TM, Mukerjee S.

J Phys Chem C Nanomater Interfaces. 2011 Nov 18;115(32). doi: 10.1021/jp2042526.

43.

Iron-based cathode catalyst with enhanced power density in polymer electrolyte membrane fuel cells.

Proietti E, Jaouen F, Lefèvre M, Larouche N, Tian J, Herranz J, Dodelet JP.

Nat Commun. 2011 Aug 2;2:416. doi: 10.1038/ncomms1427.

PMID:
21811245
44.

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Sistigu A, Viaud S, Chaput N, Bracci L, Proietti E, Zitvogel L.

Semin Immunopathol. 2011 Jul;33(4):369-83. doi: 10.1007/s00281-011-0245-0. Epub 2011 May 25. Review.

PMID:
21611872
45.

IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use.

Rizza P, Capone I, Moretti F, Proietti E, Belardelli F.

Expert Rev Vaccines. 2011 Apr;10(4):487-98. doi: 10.1586/erv.11.9. Review.

PMID:
21506646
46.

Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide.

Moschella F, Valentini M, Aricò E, Macchia I, Sestili P, D'Urso MT, Alessandri C, Belardelli F, Proietti E.

Cancer Res. 2011 May 15;71(10):3528-39. doi: 10.1158/0008-5472.CAN-10-4523. Epub 2011 Mar 28.

47.

Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.

Sistigu A, Bracci L, Valentini M, Proietti E, Bona R, Negri DR, Ciccaglione AR, Tritarelli E, Nisini R, Equestre M, Costantino A, Marcantonio C, Santini SM, Lapenta C, Donati S, Tataseo P, Miceli M, Cara A, Federico M.

Vaccine. 2011 Apr 18;29(18):3465-75. doi: 10.1016/j.vaccine.2011.02.059. Epub 2011 Mar 5.

PMID:
21382480
48.

Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.

Schiavoni G, Sistigu A, Valentini M, Mattei F, Sestili P, Spadaro F, Sanchez M, Lorenzi S, D'Urso MT, Belardelli F, Gabriele L, Proietti E, Bracci L.

Cancer Res. 2011 Feb 1;71(3):768-78. doi: 10.1158/0008-5472.CAN-10-2788. Epub 2010 Dec 13.

49.

Normative data for lung function and exhaled nitric oxide in unsedated healthy infants.

Fuchs O, Latzin P, Thamrin C, Stern G, Frischknecht P, Singer F, Kieninger E, Proietti E, Riedel T, Frey U.

Eur Respir J. 2011 May;37(5):1208-16. doi: 10.1183/09031936.00125510. Epub 2010 Nov 25.

50.

Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.

Palermo B, Del Bello D, Sottini A, Serana F, Ghidini C, Gualtieri N, Ferraresi V, Catricalà C, Belardelli F, Proietti E, Natali PG, Imberti L, Nisticò P.

Cancer Res. 2010 Sep 15;70(18):7084-92. doi: 10.1158/0008-5472.CAN-10-1326. Epub 2010 Sep 7.

Supplemental Content

Loading ...
Support Center